Valvulopatía por uso de ergotamina

Quintana, Efrén Martínez; León, Rafael Llorens; Martínez, Elena Redondo; Lago, Vicente Nieto; Cabrera, Francisco; Kastanovitz, Egon Gross

doi:10.1157/13070513

Search citation statements

Order By: Relevance

Paper Sections

Select...

Safety Of Psychedelics1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2009

2023

Publication Types

Select...

Article4

Book2

Relationship

Self Cite0

Independent6

Authors

Journals

Cited by 7 publications

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although rare, ergotamine‐derived dugs have been associated with retroperitoneal fibrosis due to the endogenous serotonin levels that may lead to fibrotic reactions 84,85 . Some case studies have also shown possible association with valvular heart disease 86,87 . However, these associations have never been proven in LSD or psilocybin.…”

Section: Safety Of Psychedelicsmentioning

confidence: 99%

Are psychedelics the answer to chronic pain: A review of current literature

et al. 2023

View full text Add to dashboard Cite

Chronic pain is a common global problem. 1 It is also a complex problem, as its development is still not fully understood. The literature suggests that several sensory and cognitive factors are involved in the perception of pain. When pain signals persist for a longer period, a peripheral and central sensitization of nociceptive circuits can occur. 2 Consequently, alterations in anatomical brain structure and functioning are observed in patients suffering from chronic pain. 3 This may explain why chronic pain is often associated with various adverse psychological effects like anxiety and depression. 4 Treatment is initially based on non-opioid analgesics like

show abstract

Section: Safety Of Psychedelicsmentioning

confidence: 99%